斯科帕龙通过调节PPARα信号通路来缓解非酒精性脂肪性肝病
Ping Huang1, Lili Yang1, Tao Liu1
1Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
European journal of pharmacology
|October 5, 2024
概括
斯科帕龙通过改善脂质代谢和减少炎症,有效治疗非酒精性脂肪性肝病 (NAFLD). 这种天然化合物向过氧体增殖器激活受体α (PPARα) 途径,提供一种潜在的治疗策略.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是一个日益严重的健康问题,治疗选择有限.
- 斯科帕龙 (Scop) 是来自Artemisia capillaris Thunb的天然化合物,对NAFLD有望出现.
- 在NAFLD中Scop的治疗效果背后的精确机制需要阐明.
研究的目的:
- 在非酒精性脂肪肝疾病 (NAFLD) 的小鼠模型中研究斯科帕龙 (Scop) 的治疗效果和潜在的分子机制.
- 确定SCOP通过哪些特定的分子标来对肝脏健康发挥有益作用.
主要方法:
- 在C57BL/6J小鼠中使用高脂肪饮食诱导NAFLD,随后进行了为期8周的Scop治疗.
- 肝脏组织mRNA测序被用来识别潜在的治疗点.
- 使用AML12肝细胞和分子对接研究的体外实验验证实了已识别的目标.
主要成果:
- 在NAFLD小鼠中,斯科帕龙治疗显著改善了脂质代谢,胰岛素敏感性和整体肝功能.
- 斯科普减轻了与高脂肪饮食相关的肝炎.
- mRNA测序和随后的验证确定了氧酶增殖器激活受体α (PPARα) 信号通路作为Scop.的关键目标.
结论:
- 斯科帕龙在非酒精性脂肪性肝病 (NAFLD) 中显示出显著的治疗潜力.
- 斯科普通过直接准和调节PPARα信号通路来缓解脂质代谢功能障碍和炎症.
- 这些发现为Scop作为NAFLD新型治疗剂的开发提供了坚实的科学基础.
相关概念视频
01:31Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70